Drawing for OXYINK

USPTO serial 87137208

OXYINK

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
RINKER, ANTHONY MICHAEL
Law office
TTAB

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 604: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with OXYINK?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Antibiotic creams; Antibiotic ointments; Antibiotic preparations; Antifungal creams for medical use; Antifungal preparations; Antimicrobial preparations for treating combat battle field wounds; Antimicrobials for dermatologic use; Oxygen for medical purposes; Oxygen for medical use; Pain relief medication; Wound dressings; Adhesive for bandages for skin wounds; Adhesive for bandages for skin wounds; Bandages for skin wounds; Bandages for skin wounds; Biological tissue cultures for medical purposes; Biological tissue grafts; Biostatic antimicrobial preparations for treating bacteria, mold, mildew, algae and yeast and for inhibiting growth of those organisms; Dressings for combat battle field wounds; Gene therapy products, namely, genetically engineered tissues for transplant purposes; Hemostatic gel matrix preparations for treating wounds; Human allograft tissue; Implantable scaffolds comprising living tissue for maintaining tissue contour; Implants comprising living tissue; Medical adhesives for binding wounds; Medicaments for recovery of combat battle field wounds; Medicated skin care preparations; Medicated skin care preparations, namely, creams, lotions, gels, toners, cleaners and peels; Medicinal creams for skin care; Mixed antibiotic preparations; Molecular complex for the delivery of non-radical oxygen for medicinal, surgical, therapeutic or veterinary purposes; Natural biomaterials for augmentation of bone and tissue for medical purposes; Pharmaceutical skin lotions; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for skin care; Pharmaceutical preparations for wounds; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for treating skin disorders; Processed human donor skin for the replacement of soft tissue; Processed human donor skin for the replacement of soft tissue; Surgical implants comprised of living tissues; Surgical implants comprising living tissue; Surgical mesh comprised primarily of living tissue; Therapeutic agents for delivery of oxygen to human tissue; Therapeutic agents for delivery of oxygen to human tissue; Vascular grafts; silver iodide for medical purposesABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 26, 2017MAB4ABANDONMENT NOTICE MAILED - INTER PARTES DECISION—
Sep 26, 2017ABN4ABANDONMENT - AFTER INTER PARTES DECISION—
Sep 26, 2017OP.TOPPOSITION TERMINATED NO. 999999—
Sep 26, 2017OP.SOPPOSITION SUSTAINED NO. 999999—
Jun 9, 2017OP.IOPPOSITION INSTITUTED NO. 999999—
Jun 9, 2017OPPFOPPOSITION PAPERS RECEIVED AT TTAB—
Jun 6, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 6, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 17, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 26, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 26, 2017XAECEXAMINER'S AMENDMENT ENTERED—
Apr 26, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Apr 26, 2017GNEAEXAMINERS AMENDMENT E-MAILED—
Apr 26, 2017CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 28, 2016GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 28, 2016GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 28, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 21, 2016DOCKASSIGNED TO EXAMINER—
Aug 18, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 16, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance